Pipeline

Our DARPin^® engine is an unlimited source of novel therapeutic designs. Explore our pipeline:

Candidate / Focus

Research

Preclinical

Phase 1

Phase 2

Phase 3

Rights

MP0250 / Multiple myeloma / IMiD combo and PI combo

Phase 2

MP0250 / EGFR-mutated NSCLC

Phase 2

MP0274 / HER2-positive cancers

Phase 1

FAP x CD40 / Immuno-oncology

Research

pMHC-DARPins / Immuno-oncology / Virology

Research

MP0310 / Immuno-oncology

Preclinical

Abicipar / wet AMD

Phase 3

Abicipar / DME

Phase 2

DARPin© candidates

Preclinical